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The explosion in the output of protein structural informa-
tion over the past ten years has resulted from the conver-
gence of technological breakthroughs in biophysics and
molecular biology. Among these advances is the use of
recombinant DNA technology to produce large quantities
of homogeneous proteins. Indeed, progress in protein
overexpression/overproduction technology has had major
impacts in other areas aside from structural biology,
including the generation of pharmaceuticals and the eluci-
dation of enzymatic catalytic mechanisms. 
The wide range of eukaryotic cell lines, including yeast,
SF9 insect cells, and Chinese hamster ovary (CHO) cells
(and their accompanying specialized vectors), that have
been developed for heterologous protein overexpression
have made it possible to effect production of milli-
gram quantities of complex proteins of great biological
interest. Nevertheless, where feasible, the most attrac-
tive source of proteins for structural, functional and
pharmaceutical applications are still the prokaryotic
expression systems (particularly Escherichia coli). No
eukaryotic cell line offers the combination of hardiness,
rapid growth, ease of genetic manipulation, and simplic-
ity associated with E. coli. Yet, although non-membrane
bound prokaryotic protein overexpression in E. coli has
become reasonably reliable, results of overexpression of
eukaryotic proteins in this organism have traditionally
been less predictable.
Only part of the problem of eukaryotic protein over-
production in E. coli is the inability of the bacteria to
carry out necessary covalent post-translational modifications
such as glycosylation or phosphorylation. A more vexing
insufficiency is its inability to produce soluble, correctly
folded protein. The basis for this deficiency is unclear
and probably multifactorial. In some cases, it is believed
that the particular eukaryotic protein product is toxic to
E. coli growth, creating a selective pressure to prevent
the protein’s build-up. In others, it is ascribed to the
foreign protein’s general instability toward proteolysis in
the bacterial intracellular environment; however, perhaps
the most favoured hypothesis is that failed overexpres-
sion results from the target eukaryotic protein’s inability
to fold efficiently to its stable, functional conformation 
in E. coli. The net outcome of attempts to overproduce
eukaryotic proteins in E. coli is often a very low level 
of expression and/or formation of significant quantities 
of insoluble inclusion bodies (aggregates of incorrectly
folded protein). 
Fortunately, several strategies to circumvent the problems
of heterologous protein expression in E. coli have been
developed, including tightly regulated expression vectors,
fusion proteins, and in vitro inclusion body solubilization.
Tight regulation of gene expression, exemplified by the
use of T7 RNA polymerase and the T7 promoter (found,
for example, in the commercially available pET/BL21DE3
system) in principle can reduce the effects of gene toxicity
by allowing heterologous expression only in the induction
phase [1]. Fusion hybrid protein methods have been par-
ticularly powerful. By genetically linking a robust protein
such as GST (glutathione-S-transferase) or MBP (maltose
binding protein) to the N terminal of the protein of
interest, enhanced quantities of soluble protein can be
obtained. These fusion products can then be readily puri-
fied using glutathione (for GST) or amylose (for MBP)
affinity columns. Unfortunately, these hybrid proteins may
display non-native behavior (see below). Moreover,
although removal of the GST or MBP by proteolytic cleav-
age may be possible, it is by no means certain and poten-
tially can lead to truncated target proteins [2]. Some
proteins which are initially isolated as inclusion bodies can
be solubilized with detergents or chaotropic salts and then
refolded by gradual detergent/salt removal [3]; however,
for most proteins, spontaneous in vitro refolding of dena-
tured proteins to native forms is unsuccessful.
Although the above protein expression methods have
been dramatically successful in particular cases, they have
not been panaceas. Over the past five years, a novel
approach, chaperone-assisted protein folding, has been
added to the expressionists’ arsenal. Chaperone proteins,
or chaperonins, were initially characterized as heat shock
proteins (hsps), bacterial proteins induced under stress.
Several families of chaperonins have now been identified
including the hsp90, hsp70, hsp60, proline isomerase, and
protein disulfide isomerase families. Most of these fami-
lies have members throughout the evolutionary tree.
Although defining the precise biological roles and mecha-
nisms of action of the chaperonins are very active areas of
research, much has already been learned about many of
them. A model has been proposed in which DnaK (hsp70
family) and GroEL (hsp60 family) work in succession to
effect protein folding in E. coli. That is, the DnaK family
functions in early protein maturation and the GroEL
family acts at a later stage [4]. 
The hsp60 family, in particular, has been heavily investi-
gated structurally and mechanistically. The first members
of this family were identified in the early 1970s as the GroE
genes of E. coli and found to participate in bacteriophage l
infection [5]. Subsequently, the GroEL, GroES genes were
found to have counterparts in chloroplasts (Rubisco subunit
binding protein) [6] and mitochondria (hsp60) [7]. In
eukaryotes, these chaperonins appear to facilitate refolding
of target proteins after the latter are transported from the
cytosol to the inside of chloroplasts or mitochondria. On the
basis of electron microscopy and X-ray crystallography,
GroEL has been shown to assemble into a back-to-back
dimer of heptamers creating a ‘double-doughnut’ [8,9].
Proteins in their partially folded form are believed to insert
within the doughnut hole where they bind and are pre-
vented from aggregating and forming insoluble inclusion
bodies (Fig. 1). The release of proteins from GroEL
appears to be coupled to GroEL ATPase activity. Further-
more, GroES binding to the complex formed between
GroEL and the target protein is also thought to facilitate
target protein release, possibly by competitive displace-
ment [10]. Protein-folding intermediates released from
GroEL are either thought to continue on to fully folded
forms or become re-bound, precluding aggregation. 
Although elucidation of the mechanistic aspects of the
chaperonins, and GroE systems in particular, is ongoing,
their utility as protein-folding reagents both in vitro and in
vivo is now well demonstrated. As shown in Table 1, they
have been used with a variety of monomeric and multi-
meric proteins to assist protein folding in vitro and expres-
sion of soluble protein in vivo. It is this latter aspect which
is particularly attractive to investigators encountering diffi-
culty with protein overproduction in E. coli. By boosting
the levels of chaperonins from 1% (the approximate
endogenous level) to greater than 10% total E. coli cell
protein, significantly enhanced soluble protein expression
has been observed. Both the hsp60 and hsp70 families
have been used successfully to increase soluble target
protein expression (Table 1). As shown, a wide variety of
enzymes, peptide hormones, and cytokines have been pro-
duced in this manner. Table 1 also shows the approximate
expression enhancements and an indication of whether the
expressed protein has been purified and/or characterized.
The general technique for carrying out chaperonin-assisted
protein expression involves transforming E. coli with sepa-
rate chaperone-expressing and target-protein-expressing
plasmids bearing distinct antibiotic resistance functions
and replication origins (for an example, see Fig. 2). In this
way, both plasmids may be stably maintained in the cell.
Typically,   promoters inducible with IPTG have been
used to drive gene expression of both target proteins and
chaperonins so that they are induced concomitantly.
An application of the GroE methodology in our mechanis-
tic studies on the protein tyrosine kinase Csk will serve as
an example, illustrating both its power as well as some
potential pitfalls. We were interested in studying the
detailed enzymatic mechanism of Csk and required mil-
ligram quantities of pure protein. E. coli was especially
desirable as the source of the recombinant enzyme not
only for the traditional reasons described above but
because endogenous protein tyrosine kinases are thought
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Figure 1
Simplified sketch of GroEL-assisted protein folding.
Table 1
Examples of chaperonin-assisted protein expression.
Target Chaperone In vitro/ Solublechap/ Purified/ References
protein family In vivo Solublectrl* Characterized†
Csk GroE‡ In vivo 4–8 Both 12–14
Lck GroE/ In vivo N.R.§ N.R. 12
DnaK#
Fyn GroE/ In vivo N.R. N.R. 12
DnaK
Dihydrofolate
reductase GroE Both 3–4 Both 17
a-Ketoacid**
dehydrogenase
kinase GroE In vivo 3–4 Both 18
Citrate synthase GroE In vitro – – 19
Lactate
dehydrogenase GroE In vitro – – 20
Tryptophanase GroE In vitro – – 21
Ornithine
transcarbamylase GroE Both N.R. N.R. 22
Pre-b-lactamase GroE In vitro – – 23
Rhodanase GroE In vitro – – 24
Rubisco GroE Both N.R. Characterized 25
a-Ketoacid††
decarboxylase GroE In vivo N.R. Both 26
NO synthase GroE In vivo >10 Both 27
Granulocyte colony
stimulating factor DnaK In vivo 6–8 N.R. 28
Human growth
hormone DnaK In vivo 2–8 N.R. 29
*Relative amount of soluble target protein expressed in the presence of
chaperonin compared with no chaperone, estimated in the references or by this
author, only for the in vivo expression systems. †Indication of whether proteins
expressed in vivo were either purified to near homogeneity and/or characterized
by enzyme assay and shown to have normal behavior. ‡Includes co-expression of
GroES and GroEL.§Not reported. #May include co-expression of DnaJ and
GrpE. **Mammalian mitochondrial branched-chain a-ketoacid dehydrogenase
kinase. ††Mammalian mitochondrial branched-chain a-ketoacid decarboxylase.
to be absent from this organism. This is particularly
important in characterizing catalytically impaired Csk
mutants where contaminating background kinase activi-
ties, despite purification efforts, can interfere with mecha-
nistic interpretations (see below). Overproduction of a
GST–Csk recombinant fusion protein from E. coli had
been reported but this hybrid protein was shown to be cat-
alytically defective compared with wild type (with specific
activity reportedly reduced by 16-fold) [11]. Furthermore,
bacterial expression of standard full-length Csk led to very
low proportions of soluble protein (ca. 10–20%) [12,13].
In contrast, when the GroESL plasmid (pREP4–groESL)
was co-introduced with the Csk expressing plasmid
(pDS56/RBSII–csk) into E. coli (see Fig. 2), the majority
of the expressed Csk protein (ca. 70–80%) was found to be
soluble under standard growth conditions (induction with
1 mM IPTG at A600=0.6–0.9, 37°C, 4 h) [13]. A Coomassie
stained SDS PAGE gel of the crude cell lysate shows that
approximately a 1:1 ratio (w/w) of wild-type Csk to GroEL
protein is produced, each representing ca. 20% of total cell
protein [13]; however, the molar quantities of Csk and
GroEL are not the same (as in a 1:1 complex) as GroEL
functions as a double heptamer. This encouraging result
was tempered by the fact that in our hands, using the pub-
lished purification of recombinant Csk from E. coli cell
extracts [13], much of the Csk (>50%) was lost in the first
chromatographic step (Phospho-Ultrogel), appearing in
the elution void volume along with GroEL. The basis for
this Csk loss was initially unclear; that is, it was not known
if the fraction of Csk protein that did not bind to the
Phospho-Ultrogel was non-native like. Nevertheless, the
Csk protein which did adhere to the Phospho-Ultrogel
resin could be eluted with a salt gradient to produce a
peak of quite pure protein, nearly free from GroEL conta-
mination. This purified recombinant Csk had similar
kinetic parameters to those reported for endogenous wild
type Csk, suggesting that the purified recombinant
enzyme was well-behaved [14].
In an effort to simplify the published Csk purification pro-
cedure, as well as to improve recovery, we made use of a
phosphotyrosine affinity column in the initial chromato-
graphic step [15]. In contrast to Phospho-Ultrogel, nearly
all (>90%) of the Csk protein stuck to the phosphotyrosine
column whereas the GroEL was removed in the void. Csk
could be eluted readily with a salt gradient in a sharp
peak. This resulted in essentially homogeneous Csk in
quantities of 25 mg L-1 E. coli cell culture (7 mg per g cell
paste, about a threefold higher recovery then reported 
in [13]). Moreover, Csk recovered from this purification
was found to behave identically, in mechanistic studies, to
material obtained from the original purification scheme.
Therefore, it seemed likely that losses suffered in the
Phospho-Ultrogel column purification step were due to a
partitioning in Csk binding between GroEL and Phospho-
Ultrogel. In contrast, with the high affinity phosphotyro-
sine–Csk SH2 interaction, Csk column binding is favored,
allowing complete separation from GroEL.
We have also used the same expression system to produce
a Csk mutant, D314E [16]. Csk D314E was prepared to
assess the role of the proposed catalytic base, Asp314, in
the reaction mechanism. The mutant enzyme had a kcat
which was reduced by approximately 10000-fold com-
pared with wild-type Csk [16]. Nevertheless, we were
able to accurately measure the mutant kinetic parameters
of D314E Csk without complications of background tyro-
sine kinase activity because of the lack of endogenous
tyrosine kinases in E. coli. These studies allowed us to
propose a new functional role for Asp314, as activator of
the g-phosphate of ATP [16]. 
Although the DNA constructs for Csk D314A and D314N
were also prepared, they failed to afford significant protein
expression (soluble or insoluble) under these GroE condi-
tions. One wonders if the application of concomitant chap-
eronin expression may make the conditions for poorly
expressed proteins even worse because of competition 
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Figure 2
DNA plasmids for GroES/GroEL expression
(pREP4–groESL) and Csk expression
(pDS56/RBSII–csk).
XhoI 0.00
HindIII 1.47
XbaI  2.45
P / R
csk
Amp-R
p D S 5 6 / R B S I I - c s k
4.75 Kb
HindIII 0.00
SalI 1.49
NheI 4.95
Km-R
lacI
P / R
groES
groEL
pREP4-groESL
5.89 Kb
in vivo for the synthetic machinery. In principle, such com-
petition might be alleviated in the future if constructs for
the chaperonins could be titrated and induced prior to the
target proteins by using different, regulatable promoters.
Conclusions
Overproduction of recombinant proteins in E. coli continues
to be an important step in their biochemical and structural
characterization. Along with other methods, chaperonins
contribute significantly to improvements in protein over-
production. Nevertheless, technical difficulties still occur
with the use of chaperonins, both in expression and purifi-
cation of the target proteins. As insights into the mol-
ecular mechanisms of chaperonin function are learned, and 
greater biochemical experience with their applications 
accrues, general principles regarding chaperonin activities
will be defined. The formulation of such principles should 
make chaperonin-assisted protein expression an even more
powerful method.
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